Masters of Pathology Series - Hematopathology Course is organized by Ebix | Oakstone Publishing, LLC.
Date of Original Release: July 15, 2018
Date Credits Expire: July 15, 2021
The program is designed both for practicing pathologists and for pathologists-in-training with emphasis on practical aspects of novel developments and updates for preparation for board examinations and maintenance of certification.
Oakstone Publishing, LLC designates this enduring material for a maximum of 11.50 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Masters of Pathology Series – Hematopathology has been registered as a Lifelong Learning (Part II) and Self-Assessment Module (SAM) to offer 11.50 credits in the American Board of Pathology's (ABPath) Continuing Certification program.
In addition to detailed coverage of hematopoietic neoplasms, the Masters of Pathology Series — Hematopathology program covers selected topics in hemostasis, thrombosis, and red blood cell pathology commonly encountered in pathology practices. Designed for both the practicing pathologist and the pathologist in training, this CME course will help you to better:
Use results of immunophenotypic, genetic, and molecular studies when diagnosing hematopoietic neoplasms
Interpret the diagnostic tests used to evaluate hemoglobinopathy, thalassemia, and selected hemostasis disorders
Understand practical aspects of new developments and updates as you prepare for exams or certification
After viewing this program, the participant will be better able to:
• Describe the current WHO diagnostic criteria for the diagnosis of hematopoietic neoplasms
• Correctly utilize and interpret results of immunophenotypic, genetic, and molecular studies in the diagnosis and classification of hematopoietic neoplasms
• Summarize and correctly interpret diagnostic tests utilized in the evaluation of hemoglobinopathy, thalassemia, and selected disorders of hemostasis
Additional details will be posted as soon as they are available.